Intelligence Search Intelligence Filter by: Industry Team Airport & AviationAutomotiveEmerging TechnologiesEnergy Food & BeverageHealth CareHospitality, Resort & GolfInsurance & Reinsurance Life SciencesMedical DevicesSports Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial InstitutionsHealth Care Finance Private Equity & Venture CapitalPublic FinanceReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyFDA RegulatoryFederal & State Energy RegulatoryFreight & Commuter RailGovernment Procurement Immigration, Nationality & Consular LawNHTSA & Motor Vehicle SafetyPolitical LawPublic Policy Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalElectronicsGreen Energy TechnologiesInformation Technology & Outsourcing IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTrademark, Copyright & Advertising Counseling International All InternationalChina EuropeJapan Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Financial Services Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & LitigationTrade Secret Noncompete Litigation Topic Accountable Care OrganizationsAmerica Invents Act (Patent Reform)Consumer Protection Act Corporate GovernanceDodd–Frank Wall Street ReformExport Control/Economic Sanctions Foreign Corrupt Practices Act (FCPA)Health Care ReformPersonalized Medicine Type ArticleBlog Post BookNewsletter VideoWhite Paper Featured All Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared Foley Blogs: CFSL Bulletin Cleantech & Nano Dashboard Insights Labor & Employment Law Perspectives Personalized Medicine Bulletin PharmaPatents Renewable Energy Outlook Wisconsin Appellate Law previous12345next Does The Experimental Use Exception Survive The AIA? 07 March 2013 PharmaPatents Now that the March 16, 2013 effective date of the first-to-file provisions of the Leahy-Smith America Invents Act (AIA) is fast-approaching, I have been reviewing... USPTO to Permit Assignees to File and Prosecute Patent Applications 22 August 2012 PharmaPatents As set forth in the final rules published in the August 14, 2012 Federal Register, assignees will be able to file and prosecute U.S. patent applications filed... Federal Circuit Upholds Fentora Patents, But Affirms Non-Infringement 26 February 2013 PharmaPatents In Cephalon, Inc. v. Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court’s finding that two Orange Book-listed patents for Cephalon’s FENTORA®... Patent Law Treaties Implementation Act Passes, Streamlining International Registration of Industrial Designs 05 December 2012 Legal News Alert: Intellectual Property On December 5, 2012, the U.S. House of Representatives passed the Patent Law Treaties Implementation Act. The Senate previously passed the Act on September... Federal Circuit Draws the Equitable Estoppel Line Before a CIP Patent 14 March 2013 PharmaPatents In Radio Systems Corp. v. Lalor, the Federal Circuit held that equitable estoppel barred Bumper Boy’s infringement charges based on one patent, but did not preclude... Nanoparticle Drug Delivery Patents in China 01 September 2012 Nanotechnology Law & Business Partner Stephen Bent and associate Max Lin authored an article that appeared in the Fall 2012 issue of Nanotechnology Law & Business titled "Nanoparticle Drug... USPTO Changes Post-Notice of Appeal Patent Term Adjustment Rules 20 August 2012 PharmaPatents In an August 16, 2012 Federal Register Notice, the USPTO announced final rules that change the way that Patent Term Adjustment (PTA) will be calculated after a Notice... USPTO Announces New, Higher USPTO Patent Fees 22 January 2013 PharmaPatents The USPTO has published the new patent fee structure that it is implementing pursuant to its fee-setting authority under the Leahy-Smith America Invents Act (AIA).... A First Look at the Final First Inventor to File Rules 19 February 2013 PharmaPatents The USPTO’s final First Inventor To File rules and Examination Guidelines were published in the February 14, 2013 edition of the Federal Register. While many of... USPTO Implements Significant Patent Term Adjustment Changes Pursuant to the AIA Technical Corrections Act 01 April 2013 PharmaPatents On April 1, 2013, the USPTO published an “interim final rule” relating to Patent Term Adjustment (PTA), to implement changes to the PTA statute embodied in the AIA... previous12345next Related 1 2 3
Does The Experimental Use Exception Survive The AIA? 07 March 2013 PharmaPatents Now that the March 16, 2013 effective date of the first-to-file provisions of the Leahy-Smith America Invents Act (AIA) is fast-approaching, I have been reviewing...
USPTO to Permit Assignees to File and Prosecute Patent Applications 22 August 2012 PharmaPatents As set forth in the final rules published in the August 14, 2012 Federal Register, assignees will be able to file and prosecute U.S. patent applications filed...
Federal Circuit Upholds Fentora Patents, But Affirms Non-Infringement 26 February 2013 PharmaPatents In Cephalon, Inc. v. Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court’s finding that two Orange Book-listed patents for Cephalon’s FENTORA®...
Patent Law Treaties Implementation Act Passes, Streamlining International Registration of Industrial Designs 05 December 2012 Legal News Alert: Intellectual Property On December 5, 2012, the U.S. House of Representatives passed the Patent Law Treaties Implementation Act. The Senate previously passed the Act on September...
Federal Circuit Draws the Equitable Estoppel Line Before a CIP Patent 14 March 2013 PharmaPatents In Radio Systems Corp. v. Lalor, the Federal Circuit held that equitable estoppel barred Bumper Boy’s infringement charges based on one patent, but did not preclude...
Nanoparticle Drug Delivery Patents in China 01 September 2012 Nanotechnology Law & Business Partner Stephen Bent and associate Max Lin authored an article that appeared in the Fall 2012 issue of Nanotechnology Law & Business titled "Nanoparticle Drug...
USPTO Changes Post-Notice of Appeal Patent Term Adjustment Rules 20 August 2012 PharmaPatents In an August 16, 2012 Federal Register Notice, the USPTO announced final rules that change the way that Patent Term Adjustment (PTA) will be calculated after a Notice...
USPTO Announces New, Higher USPTO Patent Fees 22 January 2013 PharmaPatents The USPTO has published the new patent fee structure that it is implementing pursuant to its fee-setting authority under the Leahy-Smith America Invents Act (AIA)....
A First Look at the Final First Inventor to File Rules 19 February 2013 PharmaPatents The USPTO’s final First Inventor To File rules and Examination Guidelines were published in the February 14, 2013 edition of the Federal Register. While many of...
USPTO Implements Significant Patent Term Adjustment Changes Pursuant to the AIA Technical Corrections Act 01 April 2013 PharmaPatents On April 1, 2013, the USPTO published an “interim final rule” relating to Patent Term Adjustment (PTA), to implement changes to the PTA statute embodied in the AIA...